DDR on DTC: Myrbetriq

Share this article:
DDR on DTC: Myrbetriq
Myrbetriq’s walking, cute little bladder is an instant icon

Kudos to Astellas and its ­Myrbetriq brand for a DTC campaign that pulls all of DTC's levers. Myrbetriq is another entrant in that DTC mainstay category of overactive bladder (OAB). We've seen a lot of approaches in this “lifestyle” category over the years, including Astellas' own pipe-people. But we've never seen a walking, cute little bladder until now. This little guy is great—an instant icon. He acts like a naughty child—personifying the disease—trying to drag our patient into the restroom at the most inconvenient times.

The :60 commercial reflects a classic problem-solution narrative. Our bad boy bladder is taken to the doctor where we learn about the benefits of Myrbetriq and see a wonderful package shot of the brand. Our little bladder pays close attention, and in the resolution scenes, he is relaxed and not bothering the patient.

I admit that I am a sucker for anthropomorphic characters in ads like the Nasonex Bee, Lamisil's Digger, even the Mucinex Slob. Such characters in or outside of DTC help define brand personality and drive memorability. In this case, the walking bladder works to help educate patients and destigmatize the condition.

The brand website reinforces the user-friendliness/helpfulness seen in the TV ad. Of course, our little bladder is there too. I expect we'll see a lot more of him. After all, it's a competitive category and there's a new kid in town making noise—in all the right ways.


Deborah Dick-Rath is the president of Epic Proportions, a healthcare communications consultancy. She can be reached at deborahdrath@optonline.net

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.